Skip to main content
EJNMMI Research

Table 2 Correlation between molecular subtypes with clinical variables and immune signatures

From: Prognostic impact of an integrative analysis of [18F]FDG PET parameters and infiltrating immune cell scores in lung adenocarcinoma

 

Group

ANOVA or Chi-square

Post hoc test

PP (n = 30)

TRU (n = 41)

PI (n = 25)

P value

Comparison

P value

Age

67.23 ± 8.581

66.63 ± 11.083

69.52 ± 8.804

0.499

PP vs. TRU

0.965

TRU vs. PI

0.479

PI vs. PP

0.665

Sex (% of F/M)

26.7/73.3

46.3/53.7

8/92

0.004

PP vs. TRU

0.154

TRU vs. PI

0.002

PI vs. PP

0.263

Stage (% of 0/I/II/III/IV)

0/43.3/30/26.7/0

12/65.9/12.2/7.3/2.4

0/60/16/8/16

0.002

PP vs. TRU

0.020

TRU vs. PI

0.043

PI vs. PP

0.990

CYT

2.21 ± 1.59

2.75 ± 2.06

6.47 ± 4.68

0.001

PP vs. TRU

0.822

TRU vs. PI

0.001

PI vs. PP

0.001

  1. TRU terminal respiratory unit, PP proximal proliferative, PI proximal inflammatory, CYT cytolytic score
Back to article page